These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

622 related articles for article (PubMed ID: 20101258)

  • 1. Advanced pancreatic carcinoma: current treatment and future challenges.
    Stathis A; Moore MJ
    Nat Rev Clin Oncol; 2010 Mar; 7(3):163-72. PubMed ID: 20101258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New therapeutic targets in pancreatic cancer.
    Lai E; Puzzoni M; Ziranu P; Pretta A; Impera V; Mariani S; Liscia N; Soro P; Musio F; Persano M; Donisi C; Tolu S; Balconi F; Pireddu A; Demurtas L; Pusceddu V; Camera S; Sclafani F; Scartozzi M
    Cancer Treat Rev; 2019 Dec; 81():101926. PubMed ID: 31739115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of systemic therapy for advanced pancreatic cancer.
    El-Rayes BF; Philip PA
    Clin Adv Hematol Oncol; 2003 Jul; 1(7):430-4. PubMed ID: 16258429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What treatment in 2017 for inoperable pancreatic cancers?
    Taieb J; Pointet AL; Van Laethem JL; Laquente B; Pernot S; Lordick F; Reni M
    Ann Oncol; 2017 Jul; 28(7):1473-1483. PubMed ID: 28459988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current Therapeutic Options for Pancreatic Ductal Adenocarcinoma.
    Bisht S; Brossart P; Feldmann G
    Oncol Res Treat; 2018; 41(10):590-594. PubMed ID: 30286472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of metastatic pancreatic cancer: Current treatment options and potential new therapeutic targets.
    Sclafani F; Iyer R; Cunningham D; Starling N
    Crit Rev Oncol Hematol; 2015 Sep; 95(3):318-36. PubMed ID: 25921418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current status in chemotherapy for advanced pancreatic adenocarcinoma.
    Cao H; LE D; Yang LX
    Anticancer Res; 2013 May; 33(5):1785-91. PubMed ID: 23645722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current management and future directions in metastatic pancreatic adenocarcinoma.
    Varghese AM; Lowery MA; Yu KH; O'Reilly EM
    Cancer; 2016 Dec; 122(24):3765-3775. PubMed ID: 27649047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pancreatic cancer: systemic combination therapies for a heterogeneous disease.
    Melisi D; Calvetti L; Frizziero M; Tortora G
    Curr Pharm Des; 2014; 20(42):6660-9. PubMed ID: 25341938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metastatic pancreatic ductal adenocarcinoma: diagnosis and treatment with a view to the future.
    Pokorny AMJ; Chin VT; Nagrial AM; Yip D; Chantrill LA
    Intern Med J; 2018 Jun; 48(6):637-644. PubMed ID: 29898269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent developments in the pharmacological treatment of advanced pancreatic cancer.
    Kulke MH
    Expert Opin Investig Drugs; 2003 Jun; 12(6):983-92. PubMed ID: 12783602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The multidisciplinary management of gastrointestinal cancer. Pancreatic cancer: from pathogenesis to cure.
    Ducreux M; Boige V; Goéré D; Deutsch E; Ezra P; Elias D; Malka D
    Best Pract Res Clin Gastroenterol; 2007; 21(6):997-1014. PubMed ID: 18070700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advanced pancreatic cancer - how to choose an adequate treatment option.
    Korkeila EA
    World J Gastroenterol; 2015 Oct; 21(38):10709-13. PubMed ID: 26478662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of chemotherapy in the treatment of advanced gastric and pancreas cancer.
    Kelsen D
    Semin Oncol; 1994 Aug; 21(4 Suppl 7):58-66. PubMed ID: 8091242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy for resectable and advanced pancreatic cancer.
    Berlin JD; Rothenberg M
    Oncology (Williston Park); 2001 Oct; 15(10):1241-9, 1254; discussion 1254-64. PubMed ID: 11702956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small molecule tyrosine kinase inhibitors and pancreatic cancer-Trials and troubles.
    Lakkakula BVKS; Farran B; Lakkakula S; Peela S; Yarla NS; Bramhachari PV; Kamal MA; Saddala MS; Nagaraju GP
    Semin Cancer Biol; 2019 Jun; 56():149-167. PubMed ID: 30314681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-angiogenic agents in pancreatic cancer: a review.
    Assifi MM; Hines OJ
    Anticancer Agents Med Chem; 2011 Jun; 11(5):464-9. PubMed ID: 21521158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Locally advanced pancreatic cancer: current therapeutic approach.
    Cardenes HR; Chiorean EG; Dewitt J; Schmidt M; Loehrer P
    Oncologist; 2006 Jun; 11(6):612-23. PubMed ID: 16794240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomes.
    McGuigan A; Kelly P; Turkington RC; Jones C; Coleman HG; McCain RS
    World J Gastroenterol; 2018 Nov; 24(43):4846-4861. PubMed ID: 30487695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The first-line treatment for advanced pancreatic cancer. Highlights from the "2010 ASCO Gastrointestinal Cancers Symposium". Orlando, FL, USA. January 22-24, 2010.
    Merl MY; Li J; Saif MW
    JOP; 2010 Mar; 11(2):148-50. PubMed ID: 20208324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.